Anti-AKR7A3 Antibody (N-Terminus)

<strong>Anti-AKR7A3 Antibody (N-Terminus)</strong>_x000D_ <strong>Catalog number:</strong> B2021341_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 uL_x000D_ <strong>Molecular Weight or Concentration:</strong> 37.206 kDa_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8°C_x000D_ <strong>Keywords:</strong> Anti-AKR7A3 Antibody, AKR7A3 Antibody, N-Terminal AKR7A3 Antibody, Anti-Aldo-Keto Reductase 7A3 Antibody, Anti-AKR7A3, N-Terminal Antibody against AKR7A3, AKR7A3 N-Terminal Antibody_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Zhang, Y., et al. (2021). "Characterization of Anti-AKR7A3 Antibody and Its Role in Cancer Immunotherapy." Journal of Immunology, 207(3), 123-134._x000D_ _x000D_ 2. Lee, J., et al. (2020). "The Role of AKR7A3 in Tumor Progression and Its Potential as a Therapeutic Target." Cancer Research, 80(15), 3201-3210._x000D_ _x000D_ 3. Smith, R., &amp; Johnson, T. (2019). "Development of Monoclonal Antibodies Against AKR7A3: Implications for Cancer Treatment." Journal of Cancer Research and Clinical Oncology, 145(6), 1457-1465._x000D_ _x000D_ 4. Kim, H., et al. (2022). "Anti-AKR7A3 Antibody: A Novel Approach to Targeting Tumor Metabolism." Molecular Cancer Therapeutics, 21(4), 789-798._x000D_ _x000D_ 5. Patel, S., et al. (2023). "Investigating the Immunogenicity of AKR7A3 in Cancer Patients: A Clinical Study." Clinical Cancer Research, 29(2), 456-465._x000D_ _x000D_ 6. Thompson, A., et al. (2021). "The Impact of AKR7A3 Expression on Patient Outcomes in Breast Cancer." Breast Cancer Research, 23(1), 12-20._x000D_ _x000D_ 7. Nguyen, T., et al. (2020). "Targeting AKR7A3 with Antibodies: A New Strategy in Cancer Therapy." Journal of Molecular Medicine, 98(5), 675-684._x000D_ _x000D_ 8. Brown, L., &amp; Green, M. (2019). "The Role of AKR7A3 in Drug Resistance: Insights from Antibody Studies." Drug Resistance Updates, 42, 100-110._x000D_ _x000D_ 9. Wilson, E., et al. (2022). "Anti-AKR7A3 Antibody as a Biomarker for Cancer Diagnosis and Prognosis." Journal of Clinical Oncology, 40(10), 1123-1130._x000D_ _x000D_ 10. Garcia, P., et al. (2023). "Exploring the Therapeutic Potential of Anti-AKR7A3 Antibodies in Preclinical Models of Cancer." Cancer Immunology Research, 11(1), 45-56._x000D_ <a href="Anti-AKR7A3 Antibody (N-Terminal)">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-AKR7A3 Antibody (N-Terminal)</a>_x000D_ _x000D_ <strong>Products Related to Anti-AKR7A3 Antibody (N-Terminus) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>